LiverScreen

LiverScreen is dedicated to advancing hospitals and healthcare through innovative screening programs. With a focus on population-based studies across European countries, LiverScreen is committed to improving the early detection and management of liver fibrosis. LiverScreen operates throughout Europe, OO, ensuring its services are accessible to a wide demographic.

Leveraging funding from the European Union’s Horizon 2020 research and innovation program, LiverScreen utilizes cutting-edge research and technology to enhance its screening capabilities. The organization’s dedication to excellence and innovation positions LiverScreen as a leader in the healthcare sector, striving to make a significant impact on public health. LiverScreen’s commitment supports better patient outcomes and contributes to the overall advancement of medical science.

LiverScreen is continually evolving to meet the dynamic needs of the healthcare industry. Our team is working diligently to complete additional information that will further showcase our capabilities and achievements. We invite the manager of LiverScreen to create a customized and exclusive company showcase and product listing on our platform to highlight your unique contributions and services.